Exact Sciences surges after marketing deal with Pfizer for cancer test
Exact Sciences Corp's shares shot up as much as 26 percent on Wednesday after the company said Pfizer Inc would share marketing expenses and co-promote the company's stool screening test for colorectal cancer.
from Reuters: Health News https://reut.rs/2nZ4TvN
http://bit.ly/2zwRqiM